$b_rich$'s Penny Bank Stocks

[ProfitScout]

$CURR News: CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Transplantation (HSCT)

Click here:
https://www.globenewswire.com/news-release/2022/05/12/2442338/0/en/CURE-Pharmaceutical-Announces-Positive-Findings-from-Study-at-Cincinnati-Children-s-Hospital-Medical-Center-CCHMC-Using-CURE-s-Proprietary-Oral-Thin-Film-OTF-High-Single-Dose-Vitam.html

About CURE Pharmaceutical

CURE Pharmaceutical is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. Among CURE's key products is its oral thin film, 40,000 IU dose Vitamin D, (Branded Nutri-Strips(TM) in the Retail Market). Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Nutri-Strips(TM) are available online at https://www.nutristripnow.com/immund3

As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.